Skip to content

Devon Christie

5 papers in the library · 63 citations · publishing 2021-2024

Papers

Sort Most recent Most cited

Chronic pain as an emergent property of a complex system and the potential roles of psychedelic therapies.

Front Pain Res (Lausanne) April 19, 2024 Maya Armstrong, Joel Castellanos, Devon Christie 15 citations

Despite research advances and urgent calls by national and global health organizations, clinical outcomes for millions of people suffering with chronic pain remain poor. We suggest bringing the lens of complexity science to this problem, conceptualizing chronic pain as an emergent property of a complex biopsychosocial system. We frame pain-related physiology, neuroscience, developmental...

MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder

Frontiers in Psychiatry November 3, 2022 Devon Christie, Berra Yazar-Klosinski, Ekaterina Nosova et al. 8 citations

IntroductionIncreasing evidence demonstrates 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy (MDMA-AT) may be a safe and effective treatment for post-traumatic stress disorder (PTSD). There is growing interest in MDMA-AT to address a range of other health challenges. Chronic pain and PTSD are frequently comorbid, reciprocally interdependent conditions, though the possible role of...

Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy

Substance Abuse Treatment Prevention and Policy May 14, 2022 Victor Mocanu, Lindsay Mackay, Devon Christie et al. 27 citations

International drug policy is rapidly evolving in tandem with promising evidence for psychedelic-assisted psychotherapy (PAP) in treating a range of mental health conditions. Canada is among the countries increasingly expanding access to psychedelic substances for therapeutic purposes. The 8-year ban on medical exemptions through the Canadian Special Access Programme was recently reversed in...

Can psychedelic-assisted psychotherapy play a role in enhancing motivation to change in addiction treatment settings?

Journal of Psychedelic Studies March 11, 2022 Mark Kang, Lindsay Mackay, Devon Christie et al. 1 citation

Abstract Despite growing availability of several evidence-based approaches in the treatment of substance use disorders, existing pharmacotherapy and psychosocial interventions continue to have significant limitations, such as low treatment retention rates and high rates of relapse. There is a need to develop new strategies and models to address these limitations and target underlying...

Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems

Frontiers in Psychiatry September 6, 2021 Elena Argento, Devon Christie, Lindsay Mackay et al. 12 citations

The COVID-19 pandemic stands to have impacts on mental health and well-being that will extend beyond its formal resolution. Before COVID-19, mental health disorders were already challenging global healthcare systems, directly accounting for 7.4% of the total burden of disease (1, 2). An estimated 1 billion people worldwide suffer from a mental health disorder, with the two most common...